hirustatin

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namehirustatin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonists
TargetsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsAngiogenesis disorderThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProteogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProteogen Inc
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorderThrombosis

Other Information

ATC CodeN/A
Related LinksN/A